{
    "organizations": [],
    "uuid": "42cbff8c219f6861799b69738b0d6819d5f48602",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-medicinova-announces-proposed-unde/brief-medicinova-announces-proposed-underwritten-public-offering-idUSASB0C4JM",
    "ord_in_thread": 0,
    "title": "BRIEF-MediciNova Announces Proposed Underwritten Public Offering",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 7 (Reuters) - MediciNova Inc:\n* MEDICINOVA ANNOUNCES PROPOSED UNDERWRITTEN PUBLIC OFFERING OF COMMON STOCK\n* MEDICINOVA INC - INTENDS TO USE PROCEEDS PRIMARILY TO CONTINUE TO FUND DEVELOPMENT OF ITS MN-166 (IBUDILAST), MN-001 (TIPELUKAST) PROGRAMSâ€‹, OTHERS Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-08T05:36:00.000+02:00",
    "crawled": "2018-02-09T06:12:37.001+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "medicinova",
        "inc",
        "medicinova",
        "announces",
        "proposed",
        "underwritten",
        "public",
        "offering",
        "common",
        "stock",
        "medicinova",
        "inc",
        "intends",
        "use",
        "proceeds",
        "primarily",
        "continue",
        "fund",
        "development",
        "ibudilast",
        "tipelukast",
        "others",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}